|
1
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song
J, Zhao X, Huang B, Shi W, Lu R, et al: A novel coronavirus from
patients with pneumonia in China, 2019. N Engl J Med. 382:727–733.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Drosten C, Günther S, Preiser W, Van Der
Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L,
Fouchier RA, et al: Identification of a novel coronavirus in
patients with severe acute respiratory syndrome. N Engl J Med.
348:1967–1976. 2003.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zaki AM, Van Boheemen S, Bestebroer TM,
Osterhaus AD and Fouchier RA: Isolation of a novel coronavirus from
a man with pneumonia in Saudi Arabia. N Engl J Med. 367:1814–1820.
2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ramadan N and Shaib H: Middle East
respiratory syndrome coronavirus (MERS-CoV): A review. Germs.
9:35–42. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Phelan AL, Katz R and Gostin LO: The novel
coronavirus originating in Wuhan, China: Challenges for global
health governance. JAMA. 323:709–710. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu Y, Ho W, Huang Y, Jin DY, Li S, Liu SL,
Liu X, Qiu J, Sang Y, Wang Q, et al: SARS-CoV-2 is an appropriate
name for the new coronavirus. Lancet. 395:949–950. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Legido-Quigley H, Asgari N, Teo YY, Leung
GM, Oshitani H, Fukuda K, Cook AR, Hsu LY, Shibuya K and Heymann D:
Are high-performing health systems resilient against the COVID-19
epidemic? Lancet. 395:848–850. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Khot WY and Nadkar MY: The 2019 novel
coronavirus outbreak-a global threat. J Assoc Physicians India.
68:67–71. 2020.PubMed/NCBI
|
|
9
|
Organization WHO: COVID-19 weekly
epidemiological update, edition 84, 22 March 2022. 2022. Accessed
on 17th May 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
|
|
10
|
Sarvepalli D: Coronavirus disease 2019: A
comprehensive review of etiology, pathogenesis, diagnosis, and
ongoing clinical trials. Cureus. 12(e8076)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Y, Shi J, Xia J, Duan J, Chen L, Yu X,
Lan W, Ma Q, Wu X, Yuan Y, et al: Asymptomatic and symptomatic
patients with non-severe coronavirus disease (COVID-19) have
similar clinical features and virological courses: A retrospective
single center study. Front Microbiol. 11(1570)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lechien JR, Chiesa-Estomba CM, Place S,
Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S,
et al: Clinical and epidemiological characteristics of 1420
European patients with mild-to-moderate coronavirus disease 2019. J
Intern Med. 288:335–344. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Aktas G: A comprehensive review on
rational and effective treatment strategies against an invisible
enemy; SARS Cov-2 infection. Exp Biomedical Res. 3:293–311.
2020.
|
|
14
|
Wu Z and McGoogan JM: Characteristics of
and important lessons from the coronavirus disease 2019 (COVID-19)
outbreak in China: Summary of a report of 72 314 cases from the
Chinese center for disease control and prevention. JAMA.
323:1239–1242. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Martins EC, da Silveira LDF, Viegas K,
Beck AD, Fioravantti Júnior G, Cremonese RV and Lora PS:
Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an
intensive care unit: A case-control study. Rev Bras Ter Intensiva.
31:63–70. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Popov GT, Baymakova M, Vaseva V,
Kundurzhiev T and Mutafchiyski V: Clinical characteristics of
hospitalized patients with COVID-19 in Sofia, Bulgaria. Vector
Borne Zoonotic Dis. 20:910–915. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma
JP, Xiao W, Wang YN, Zhong MH, Li CH, et al: Clinical
characteristics of novel coronavirus cases in tertiary hospitals in
Hubei Province. Chin Med J (Engl). 133:1025–1031. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen
ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, et al: Comorbidity and
its impact on 1590 patients with COVID-19 in China: A nationwide
analysis. Eur Respir J. 55(200054)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sharov KS: SARS-CoV-2-related pneumonia
cases in pneumonia picture in Russia in March-May 2020: Secondary
bacterial pneumonia and viral co-infections. J Glob Health.
10(020504)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cosentino F, Moscatt V, Marino A,
Pampaloni A, Scuderi D, Ceccarelli M, Benanti F, Gussio M, Larocca
L, Boscia V, et al: Clinical characteristics and predictors of
death among hospitalized patients infected with SARS-CoV-2 in
Sicily, Italy: A retrospective observational study. Biomed Rep.
16(34)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Meng X, Deng Y, Dai Z and Meng Z: COVID-19
and anosmia: A review based on up-to-date knowledge. Am J
Otolaryngol. 41(102581)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S,
Huang H, Zhang L, Zhou X, Du C, et al: Risk factors associated with
acute respiratory distress syndrome and death in patients with
coronavirus disease 2019 pneumonia in Wuhan, China. JAMA.
180:934–943. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Peiris JS, Chu CM, Cheng VC, Chan K, Hung
I, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, et al: Clinical
progression and viral load in a community outbreak of
coronavirus-associated SARS pneumonia: A prospective study. Lancet.
361:1767–1772. 2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
WHO. Summary of probable SARS cases with
onset of illness from 1 November 2002 to 31 July 2003. Dec 31,
2003. www.who.int/csr/sars/country/table2004_04_21/en/.
Accessed 19 Jan 2020.
|
|
25
|
WHO. Middle East respiratory syndrome
coronavirus (MERS-CoV). November, 2019. www.who.int/emergencies/mers-cov/en/. Accessed 19 Jan
2020.
|
|
26
|
Norooznezhad AH, Najafi F, Riahi P,
Moradinazar M, Shakiba E and Mostafaei S: Primary symptoms,
comorbidities, and outcomes of 431 hospitalized patients with
confirmative RT-PCR results for COVID-19. Am J Trop Med Hyg.
103:834–837. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Nikpouraghdam M, Jalali Farahani AJ,
Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari
NJ, Izadi M, Qazvini A, et al: Epidemiological characteristics of
coronavirus disease 2019 (COVID-19) patients in IRAN: A single
center study. J Clin Virol. 127(104378)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ye Q, Wang B and Mao J: The pathogenesis
and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect.
80:607–613. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Farrell JM, Zhao CY, Tarquinio KM and
Brown SP: Causes and consequences of COVID-19-associated bacterial
infections. Front Microbiol. 12(682571)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tan L, Wang Q, Zhang D, Ding J, Huang Q,
Tang YQ, Wang Q and Miao H: Lymphopenia predicts disease severity
of COVID-19: A descriptive and predictive study. Signal Transduct
Target Ther. 5(33)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Henry BM, Aggarwal G, Wong J, Benoit S,
Vikse J, Plebani M and Lippi G: Lactate dehydrogenase levels
predict coronavirus disease 2019 (COVID-19) severity and mortality:
A pooled analysis. Am J Emerg Med. 38:1722–1726. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Shi J, Li Y, Zhou X, Zhang Q, Ye X, Wu Z,
Jiang X, Yu H, Shao L, Ai JW, et al: Lactate dehydrogenase and
susceptibility to deterioration of mild COVID-19 patients: A
multicenter nested case-control study. BMC Med.
18(168)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Porfidia A and Pola R: Venous
thromboembolism in COVID-19 patients. J Thromb Haemost.
18:1516–1517. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Demelo-Rodríguez P, Cervilla-Muñoz E,
Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M,
Toledo-Samaniego N, García-García A, García-Fernández-Bravo I, Ji
Z, de-Miguel-Diez J, et al: Incidence of asymptomatic deep vein
thrombosis in patients with COVID-19 pneumonia and elevated D-dimer
levels. Thromb Res. 192:23–26. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang L, Feng X, Zhang D, Jiang C, Mei H,
Wang J, Zhang C, Li H, Xia X, Kong S, et al: Deep vein thrombosis
in hospitalized patients with COVID-19 in Wuhan, China: Prevalence,
risk factors, and outcome. Circulation. 142:114–128.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zou Y, Guo H, Zhang Y, Zhang Z, Liu Y,
Wang J, Lu H and Qian Z: Analysis of coagulation parameters in
patients with COVID-19 in Shanghai, China. Biosci Trends.
14:285–289. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Mucha SR, Dugar S, McCrae K, Joseph D,
Bartholomew J, Sacha GL and Militello M: Coagulopathy in COVID-19:
Manifestations and management. Cleve Clin J Med. 87:461–468.
2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Montazersaheb S, Hosseiniyan Khatibi SM,
Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, Farahzadi R
and Ghasemnejad T: COVID-19 infection: An overview on cytokine
storm and related interventions. Virol J. 19(92)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Poggiali E, Zaino D, Immovilli P, Rovero
L, Losi G, Dacrema A, Nuccetelli M, Vadacca GB, Guidetti D,
Vercelli A, et al: Lactate dehydrogenase and C-reactive protein as
predictors of respiratory failure in CoVID-19 patients. Clin Chim
Acta. 509:135–138. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wu Y, Potempa LA, El Kebir D and Filep JG:
C-reactive protein and inflammation: Conformational changes affect
function. Biol Chem. 396:1181–1197. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Bajwa EK, Khan UA, Januzzi JL, Gong MN,
Thompson BT and Christiani DC: Plasma C-reactive protein levels are
associated with improved outcome in ARDS. Chest. 136:471–480.
2009.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Khalid A, Ali Jaffar M, Khan T, Abbas Lail
R, Ali S, Aktas G, Waris A, Javaid A, Ijaz N and Muhammad N:
Hematological and biochemical parameters as diagnostic and
prognostic markers in SARS-COV-2 infected patients of Pakistan: A
retrospective comparative analysis. Hematology. 26:529–542.
2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hilal N and Mushtaq A: Prevalence of
anemia in geriatric population of Kashmir: A hospital based study:
Anemia: An unrecognized sign in geriatric patients. Ann Med
Physiol. 14:26–30. 2017.
|
|
44
|
Shahnawaz M, Wani AH, Upadhyay S, Pattnaik
S, Mustafa H, Azad AM, Arjumand Farooq SS, Nabi W, Hassan Y, Din
Wani NU, et al: Clinico-radiological profile of COVID-19 in
Kashmiri population: A descriptive study. J Family Med Prim Care.
10:1473–1478. 2021.PubMed/NCBI View Article : Google Scholar
|
